Paratek Pharmaceuticals, Inc. Quarterly Interest Expense in USD from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Paratek Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q2 2023.
  • Paratek Pharmaceuticals, Inc. Interest Expense for the quarter ending June 30, 2023 was $5.29M, a 16.3% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. Interest Expense for the twelve months ending June 30, 2023 was $18.9M, a 6.05% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. annual Interest Expense for 2022 was $18.1M, a 4.08% increase from 2021.
  • Paratek Pharmaceuticals, Inc. annual Interest Expense for 2021 was $17.4M, a 14% decline from 2020.
  • Paratek Pharmaceuticals, Inc. annual Interest Expense for 2020 was $20.2M, a 23.4% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $18.9M $5.29M +$741K +16.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $18.1M $4.48M -$3K -0.07% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $18.1M $4.56M +$168K +3.83% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 $18M $4.54M +$169K +3.87% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $17.8M $4.55M +$202K +4.65% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $17.6M $4.48M +$172K +3.99% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $17.4M $4.39M -$875K -16.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $18.3M $4.37M -$811K -15.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $19.1M $4.34M -$627K -12.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $19.7M $4.31M -$519K -10.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $20.2M $5.27M +$639K +13.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $19.6M $5.18M +$618K +13.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $19M $4.97M +$980K +24.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $18M $4.83M +$1.6M +49.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $16.4M $4.63M +$1.44M +45% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 $15M $4.56M +$1.18M +34.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $13.8M $3.99M +$1.09M +37.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $12.7M $3.23M +$1.72M +114% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $11M $3.19M +$1.78M +126% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 $9.21M $3.38M +$1.98M +140% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $7.23M $2.9M +$1.78M +158% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $5.45M $1.51M +$375K +33.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $5.08M $1.41M +$558K +65.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 $4.52M $1.41M +$588K +71.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $3.93M $1.13M +$308K +37.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $3.63M $1.13M +$402K +55.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $3.22M $855K +$157K +22.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 $3.07M $820K +$773K +1645% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $2.29M $818K +$793K +3172% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $1.5M $730K +$730K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $770K $698K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 $47K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $25K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q3 2011 $2K* -$1K -33.3% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-10
Q2 2011 $2K* -$2K -50% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-15
Q3 2010 $3K* Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 $4K* Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.